Post-Irradiation Sinus Mucosa Disease in Nasopharyngeal Carcinoma Patients Treated with Intensity-Modulated Proton Therapy.
07/01/2022
/
Publications
/
IMPT
VMAT
This study by the researchers from Taiwan compared the incidence and severity of chronic rhinosinusitis (CRS) in NPC patients who were treated with IMPT (n=53)...
Proton therapy in Groningen: clinical practice and future perspectives
09/08/2021
/
Event
/
Model-based approach
Ramp-up
Overview of the clinical practice of proton therapy in Groningen, The Netherlands:
- Evolution of the number of patients per indication
- Model-based...
Physical function, body mass index, and fitness outcomes in children, adolescents, and emerging adults with craniopharyngioma from proton therapy through five years of follow-up.
13/09/2022
/
Publications
This study evaluated the health outcomes of 94 children with craniopharyngioma treated by protons. Body mass index, physical function and cardiopulmonary...
Incidence of brainstem toxicity following high-dose conformal PT for adult skull-base malignancies.
13/07/2022
/
Publications
This study by the Jacksonville group reported the incidence of brainstem toxicity after proton therapy. 163 patients with skull base chordoma or chondrosarcoma...
Pencil-beam scanning proton therapy for the treatment of glomus jugulare tumours.
13/08/2022
/
Publications
/
IMPT
Pencil Beam Scanning - PBS
This study by the group from Prague, Czech Republic, reported early outcomes of 12 patients with glomus jugulare tumours (GJT) treated with IMPT to a median...
Treating head and neck cancer with proton therapy
30/12/2020
/
White Paper
/
Toxicity
IMRT
Dosimetry
Proton particles do not deposit exit dose, which allows proton therapy to spare normal tissues distal to the tumor target. This is particularly useful for...
Proton Therapy for Head and Neck Cancer: Selection and management
14/09/2022
/
Webinar
During ISOP 2022, Brandon Gunn presented the webinar "Proton Therapy for Head and Neck Cancer: Selection and management". Watch the webinar above.
Proton and carbon ion beam treatment with active raster scanning method in 147 patients with skull base chordoma at the Heidelberg Ion Beam Therapy Center-a single-center experience.
15/11/2022
/
Publications
/
Survival
This study from the Heidelberg group compared the results of 111 skull-base chordoma patients treated with carbon ion of 66 GyRBE and 36 patients treated with...
Particle beam therapy for nasopharyngeal cancer: A systematic review and meta-analysis.
15/11/2022
/
Publications
/
Survival
This is a systematic review on particle beam including proton and carbon ion therapy for primary or recurrent nasopharyngeal cancer (NPC). Twenty-six eligible...
Outcomes and Toxicities of Nonmedullary Thyroid Tumors Treated with Proton Beam Radiation Therapy.
15/11/2022
/
Publications
/
Survival
This retrospective study evaluated 22 patients with thyroid cancer treated with PBT to a total dose of 60 GyRBE adjuvantly and 70 GyRBE for gross disease. With...
Cookies policy
If you continue browsing this website, you agree to the use of cookies in order to provide you with services and offers tailored to your own interests.
Manage your cookie preferences
Respect for your privacy is still a priority for us at IBA.
Functional cookies ensure that the website runs smoothly. They cannot be turned off. By setting your preferences, you can turn the use of these cookies on and off on our website, although these settings will only be valid on the device you are currently using.